Change genre preferences here
Humana (NYSE: HUM) will provide compensation for improvement in quality metrics such as hospital-associated infection rates, care coordination and palliative care. These areas are intended to produce improvements in a patient's health outcomes, safety and experience.
Humana will measure participating hospitals' performance by using metrics from two certification programs developed by The Joint Commission, the nation's oldest health care accreditation agency. Participating hospitals will need to receive the Integrated Care Certification and Palliative Care Coordination Certification from The Joint Commission.
"These key Joint Commission certifications require that participating hospitals engage patients more seamlessly across the entire continuum of care, and we're pleased to work with Humana to create additional value for the hospitals that achieve them," Brian Enochs, executive vice president of business development and marketing with The Joint Commission, said in the release.
The release did not specify how much the hospitals would be paid or the timeframe for improvements for hospitals.
The incentive program furthers Humana's goal moving to a value-based model for care and payment for the members of its health plans. Many health plans, including Humana's, are moving to models that focus on paying for good patient health outcomes, rather than simply paying fees for services provided.
Ensuring care integration and coordination across the health care spectrum for its plan members also has been a major focus for Humana.
The company recently announced that it would partner with Landmark Health LLC, a Huntington Beach, Calif.-based home-based medical care company, to provide in-home behavioral and palliative care coordination to Humana's Medicare Advantage members with complex health needs related to chronic illness in several states.
"This study shows that the liver transplant itself regulates the host's immune responses. Compared to the other organs, the liver is immunologically a very active organ, so it is capable of regulating the immune responses against itself," explained study author Dr. Timucin Taner, a transplant surgeon at the Mayo Clinic in Rochester, Minn.